caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1881694347

Paul FarabaughMD

UrologyTupelo, MSI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Paul Farabaugh's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 39 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HEALTHTRONICS LABORATORY SOLUTIONS LLC84185
William Henson
Diagnostic Radiology · Tupelo, MS
64148
Eric Emig
Diagnostic Radiology · Tupelo, MS
61147
Anthony Junck
Diagnostic Radiology · Tupelo, MS
50107
FLOWERS, HARVEY41173
Laboratory Corporation Of America Holdings
Clinical Laboratory · Birmingham, AL
4081
Clinton Smith
Diagnostic Radiology · Tupelo, MS
3798
Jon Posey
Urology · Tupelo, MS
3068
NORTH MISSISSIPPI MEDICAL CENTER, INC.3072
Clarance Farmer
Urology · Tupelo, MS
2984
GRISWOLD, RICHARD2880
Jonathan Kalish
Urology · Tupelo, MS
2788
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,773
Unique beneficiaries
—
Total services
11,182
Distinct HCPCS
37
Medicare payment
$220K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 63 Urology providers in MS — above median (cohort median 9,921).
PRESCRIBING · PART D · 2024
Total Rx claims
1,971
Beneficiaries
—
Total drug cost
$6.4M
Distinct drugs
29
Brand share
71.4%
Top prescribed drugs
Alfuzosin Hcl332 claims
Relugolix312 claims
Enzalutamide201 claims
Apalutamide181 claims
Sulfamethoxazole/Trimethoprim157 claims
QUALITY · MIPS · 2024
Final MIPS score
95.8
Quality
91.6
Cost
74.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.88%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
44
By payment type
Food and Beverage$1K